Treatment Outcomes for HIV‐Uninfected Patients with Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis
Open Access
- 15 August 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (4) , 496-502
- https://doi.org/10.1086/590005
Abstract
Background. Multidrug-resistant (MDR) tuberculosis (TB) is more difficult to treat than is drug-susceptible TB. To elucidate the optimal therapy forKeywords
This publication has 20 references indexed in Scilit:
- Extensively Drug-Resistant Tuberculosis in South Korea: Risk Factors and Treatment Outcomes among Patients at a Tertiary Referral HospitalClinical Infectious Diseases, 2008
- Evolution of the Extensively Drug-Resistant F15/LAM4/KZN Strain of Mycobacterium tuberculosis in KwaZulu-Natal, South AfricaClinical Infectious Diseases, 2007
- Impact of Extensive Drug Resistance on Treatment Outcomes in Non-HIV-Infected Patients with Multidrug-Resistant TuberculosisClinical Infectious Diseases, 2007
- Clinical and operational value of the extensively drug-resistant tuberculosis definitionEuropean Respiratory Journal, 2007
- Management of multidrug-resistant tuberculosis and patients in retreatmentEuropean Respiratory Journal, 2005
- Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort studyThe Lancet, 2005
- American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of AmericaAmerican Journal of Respiratory and Critical Care Medicine, 2003
- The Treatment of Multidrug-Resistant Tuberculosis in TurkeyNew England Journal of Medicine, 2001
- Epidemiology of HIV infection in the Republic of KoreaJournal of Korean Medical Science, 1999
- Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.American Journal of Respiratory and Critical Care Medicine, 1994